311 related articles for article (PubMed ID: 8468460)
1. Effect of transforming growth factor-beta on early and late activation events in human T cells.
Ahuja SS; Paliogianni F; Yamada H; Balow JE; Boumpas DT
J Immunol; 1993 Apr; 150(8 Pt 1):3109-18. PubMed ID: 8468460
[TBL] [Abstract][Full Text] [Related]
2. Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression.
Ruegemer JJ; Ho SN; Augustine JA; Schlager JW; Bell MP; McKean DJ; Abraham RT
J Immunol; 1990 Mar; 144(5):1767-76. PubMed ID: 2407783
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic studies of transforming growth factor-beta inhibition of IL-2-dependent activation of CD3- large granular lymphocyte functions. Regulation of IL-2R beta (p75) signal transduction.
Ortaldo JR; Mason AT; O'Shea JJ; Smyth MJ; Falk LA; Kennedy IC; Longo DL; Ruscetti FW
J Immunol; 1991 Jun; 146(11):3791-8. PubMed ID: 1851793
[TBL] [Abstract][Full Text] [Related]
4. Co-stimulation of T cell proliferation by transforming growth factor-beta 1.
Lee HM; Rich S
J Immunol; 1991 Aug; 147(4):1127-33. PubMed ID: 1831218
[TBL] [Abstract][Full Text] [Related]
5. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction.
Tao X; Davis LS; Hashimoto K; Lipsky PE
J Pharmacol Exp Ther; 1996 Jan; 276(1):316-25. PubMed ID: 8558449
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes.
Inge TH; McCoy KM; Susskind BM; Barrett SK; Zhao G; Bear HD
J Immunol; 1992 Jun; 148(12):3847-56. PubMed ID: 1602133
[TBL] [Abstract][Full Text] [Related]
7. Novel mechanism for inhibition of human T cells by glucocorticoids. Glucocorticoids inhibit signal transduction through IL-2 receptor.
Paliogianni F; Ahuja SS; Balow JP; Balow JE; Boumpas DT
J Immunol; 1993 Oct; 151(8):4081-9. PubMed ID: 8409387
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta inhibits human T-cell proliferation through multiple targets.
Fox FE; Capocasale RJ; Ford HC; Lamb RJ; Moore JS; Nowell PC
Lymphokine Cytokine Res; 1992 Dec; 11(6):299-305. PubMed ID: 1477183
[TBL] [Abstract][Full Text] [Related]
9. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
Kasid A; Bell GI; Director EP
J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R alpha gene expression at multiple levels.
Anastassiou ED; Paliogianni F; Balow JP; Yamada H; Boumpas DT
J Immunol; 1992 May; 148(9):2845-52. PubMed ID: 1374102
[TBL] [Abstract][Full Text] [Related]
11. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.
Tocci MJ; Matkovich DA; Collier KA; Kwok P; Dumont F; Lin S; Degudicibus S; Siekierka JJ; Chin J; Hutchinson NI
J Immunol; 1989 Jul; 143(2):718-26. PubMed ID: 2472451
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by anti-HLA class II monoclonal antibodies of monoclonal antibody OKT3-induced T cell proliferation. Studies at the mRNA level.
Racioppi L; Moscarella A; Ruggiero G; Manzo C; Ferrone S; Fontana S; Zappacosta S
J Immunol; 1990 Dec; 145(11):3635-40. PubMed ID: 1978847
[TBL] [Abstract][Full Text] [Related]
13. CD28 co-stimulation regulates the effect of transforming growth factor-beta1 on the proliferation of naïve CD4+ T cells.
Sung JL; Lin JT; Gorham JD
Int Immunopharmacol; 2003 Feb; 3(2):233-45. PubMed ID: 12586604
[TBL] [Abstract][Full Text] [Related]
14. IL-1 alpha induces expression of active transforming growth factor-beta in nonproliferating T cells via a post-transcriptional mechanism.
Bristol LA; Ruscetti FW; Brody DT; Durum SK
J Immunol; 1990 Dec; 145(12):4108-14. PubMed ID: 2175324
[TBL] [Abstract][Full Text] [Related]
15. Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta.
Smyth MJ; Strobl SL; Young HA; Ortaldo JR; Ochoa AC
J Immunol; 1991 May; 146(10):3289-97. PubMed ID: 1827481
[TBL] [Abstract][Full Text] [Related]
16. Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products.
Elner SG; Elner VM; Bian ZM; Lukacs NW; Kurtz RM; Strieter RM; Kunkel SL
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):446-55. PubMed ID: 9040478
[TBL] [Abstract][Full Text] [Related]
17. Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1.
Minguillón J; Morancho B; Kim SJ; López-Botet M; Aramburu J
J Leukoc Biol; 2005 May; 77(5):748-58. PubMed ID: 15716327
[TBL] [Abstract][Full Text] [Related]
18. Anti-CD3 antibody-induced expression of both p55 and p75 chains of the high affinity interleukin-2 receptor on human T lymphocytes is inhibited by cyclosporin A.
Foxwell BM; Simon J; Herrero JJ; Taylor D; Woerly G; Cantrell D; Ryffel B
Immunology; 1990 Jan; 69(1):104-9. PubMed ID: 2312149
[TBL] [Abstract][Full Text] [Related]
19. Contrasting effect of transforming growth factor type beta 1 (TGF-beta 1) on proliferation and interleukin-2 receptor expression in activated and rapidly cycling immature (CD3-CD4-CD8-) thymocytes.
Dupuy d'Angeac A; Rème T; Monier S; Gao Q; Duperray C; Jullien P; Dornand J
J Cell Physiol; 1993 Jan; 154(1):44-52. PubMed ID: 8419406
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease.
Benahmed M; Meresse B; Arnulf B; Barbe U; Mention JJ; Verkarre V; Allez M; Cellier C; Hermine O; Cerf-Bensussan N
Gastroenterology; 2007 Mar; 132(3):994-1008. PubMed ID: 17324400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
